SCHEMBL2979701

SCHEMBL2979701

CCOC(=O)Cc1ccc(Oc2ccc(C(=O)NCCc3ccc(Cl)cc3)cc2)c(Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
SMN1; SMN2 Q16637 3/20 0.49
PPARA Q07869 2/20 0.49
ALDH1A1 P00352 1/20 0.49
FABP2 P12104 1/20 0.49
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
PTGDR2 Q9Y5Y4 11/20 0.48
MAPT P10636 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
GFER P55789 1/20 0.47
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2991991 0.90 GAA (0.53) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2985684 0.90 GAA (0.53) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2991855 0.87 GAA (0.54) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2990144 0.86 SMN1; SMN2 (0.49) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2987363 0.85 SMN1; SMN2 (0.48) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2977420 0.85 PTGDR2 (0.60) GAAPTGDR2
SCHEMBL11365241 0.84 MAPT (0.63) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2985484 0.83 GAA (0.46) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2991888 0.82 GAA (0.53) GAASMN1; SMN2PPARAALDH1A1FABP2
SCHEMBL2986442 0.82 PPARA (0.45) GAASMN1; SMN2PPARAALDH1A1FABP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492437-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2013-07-23 US disclosed
EP-2057115-B9 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-12-26 EP disclosed
EP-2057115-B1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC (US) 2012-10-03 EP disclosed
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2012-08-09 US disclosed
US-8183289-B2 4-substituted phenoxyphenylacetic acid derivatives ARRAY BIOPHARMA INC. (US) 2012-05-22 US disclosed
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA INC. (US) 2010-07-08 US disclosed
EP-2057115-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES Array Biopharma, Inc. (US) 2009-05-13 EP disclosed
WO-2008024746-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES ARRAY BIOPHARMA, INC. (US) 2008-02-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173955-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 GAA 2523/4885SMN1; SMN2 3361/4885PPARA 874/4885
US-20120202854-A1 4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES CD22, HRH2, CD74 GAA 2523/4885SMN1; SMN2 3361/4885PPARA 874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.